InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.400
+0.010 (0.72%)
Oct 30, 2025, 4:00 PM EDT - Market closed
InterCure Market Cap
InterCure has a market cap or net worth of $77.33 million as of October 30, 2025. Its market cap has decreased by -10.56% in one year.
Market Cap
77.33M
Enterprise Value
116.94M
1-Year Change
-10.56%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from $1.78M to $77.33M, an increase of 4,241.71%. That is a compound annual growth rate of 28.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 77.33M | 3.65% |
| Dec 31, 2024 | 74.61M | 27.32% |
| Dec 31, 2023 | 58.60M | -62.52% |
| Dec 29, 2022 | 156.35M | -47.90% |
| Dec 30, 2021 | 300.11M | 119.01% |
| Dec 31, 2020 | 137.03M | 17.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 764.27B |
| Johnson & Johnson | 455.12B |
| AbbVie | 403.78B |
| UnitedHealth Group | 312.76B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 217.99B |